Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study.

Wu X, Lu K, Guo Q, Liu C, Ji P, Shi D

Open source

DOI
10.1186/s12880-026-02650-3
Published
2026 Aug 10
Container
BMC medical imaging
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12880-026-02650-3,
  title = {Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study.},
  author = {Wu X and Lu K and Guo Q and Liu C and Ji P and Shi D},
  year = {2026},
  journal = {BMC medical imaging},
  doi = {10.1186/s12880-026-02650-3},
  url = {https://doi.org/10.1186/s12880-026-02650-3}
}

RIS

TY  - JOUR
TI  - Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study.
AU  - Wu X
AU  - Lu K
AU  - Guo Q
AU  - Liu C
AU  - Ji P
AU  - Shi D
PY  - 2026
JO  - BMC medical imaging
DO  - 10.1186/s12880-026-02650-3
UR  - https://doi.org/10.1186/s12880-026-02650-3
ER  - 

APA

X, W., K, L., Q, G., C, L., P, J., & D, S. (2026). Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study.. BMC medical imaging. https://doi.org/10.1186/s12880-026-02650-3

Source records